kolo 7h?
SEP 27 2006
510(k) SUMMARY
ASCLEPION LASER TECHNOLOGIES GmbH
TattooStar family
This 510(k) summary of safety and effectiveness for the Asclepion Laser Technologies
GmbH TattooStar family is submitted in accordance with the requirements of 21 CFR

907.92 and follows Office of Device Evaluation Guidance concerning the organization

and content of a 510(k) summary.

Applicant: ASCLEPION LASER TECHNOLOGIES GmbH

Am Semmicht 1A
07755 Jena, Germany
Contact Person: Mr Reinhard Thieme
Quality Assurance and
International Regulatory Affairs

Phone: +49 3641 77 00 251

Fax: +49 3641 77 00 102

e-mail: reinhard.thieme@asclepion.com

Preparation Date: June 18th, 2006

Device Name: TattooStar R

Common Name: TattooStar R

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.481

Equivalent Device: RubyStar

Device Description: The TattooStar R is a q-switched solid state lasers emitting
wavelengths of 694 nm (Rubylaser). It consists a laser
enclosure and optic delivery system (articulated mirror arm).

Intended Use: The TattooStar R is indicated of cutting, vaporization or
ablation of soft tissue. This includes tattoo removal and
treatment of benign pigmented lesions.

Comparison to: The TattooStar R is substantially equivalent to the RubyStar,
with the same principles of operation, and the same
indication for use ,the same wavelength but without a long
pulsed mode which is used for hair removal.

Seite 1 von 2

KO607P9

Nonclinical Performance Data: | None

Clinical Performance Data: None

Conclusion: The TattooStar R is another safe and effective device
for the removal of tattoos and pigmented lesions and
for ablation, cutting, vaporization of soft tissue for
general dermatology.

Additional Information : None

Seite 2 von 2

? g DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
“esa Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Asclepion Laser Technologies GmbH
% Reinhard Thieme
Quality Assurance Manager
Arn Semmicht 1A SEP 27 2006 .
07755 Jena, Germany /
Re: K060787 ,
Trade/Device Name: TattooStar R
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery
and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: August 24, 2006
Received: August 28, 2006
Dear Reinhard Thieme:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legaily marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not reauire approval of a premarkci approval application (PMA). You may,
therefore. market the device. subiect to the genera! controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
[f your device is classified (see above) into either class [7 (Special Controls) or class II (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federai Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product
radiation control] provisions (Sections $31-542 of the Act); 21 CFR 1000-1050.

Page 2 — Reinhard Thieme ,
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain other
general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Whe,

\ \ Mi Kerson

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

|
|
INDICATIONS FOR USE STATEMENT
510(k) Number (if known): K060787
Device Name: TattooStar R .
Indications for Use: :
The TattooStar R is intended for use for cutting, vaporization and ablation of soft
tissue and the removal of tattoos and benign pigment lesion.
/ Some examples of pigment lesions are:
Lentigines, Café-au-lait-blotches, Ephalides, BenignNaevi such as Naevus of Ota,
Naevus of Ito, Epidermal Naevi, Congenital Naevi, Beckers Naevi, Blue Nevus,
Naevus Spillus and Mongolian Spot.
: Prescription Use X AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF
NEEDED)
_ | _Sf ; iT
coma A be ne (ODE)
NE
iDivision Sign-Off)
Division of General, Restorative,
and Neurological Devices
510(k) number 0048 TF

